Laura Rubbia-Brandt is Director of the Division of Clinical Pathology, Geneva University Hospital, Switzerland, and full professor in pathology where she teaches GI and liver Pathology at Geneva Medical School. She received her medical education at the University of Geneva and her specialty training in the Division of Clinical Pathology, Geneva University Hospital Switzerland and Hôpital Beaujon, Paris, France.
She is president of the Swiss Hepato-Biliary pathology group, which is a section of the Swiss society of pathology. She is also president of the Swiss society of pathology, an active member of the board of the Swiss association for the study of the liver, referent pathologist of the Swiss Hepatitis C Cohort Study Group, and member of the GI pathology group of the Swiss Institute for Applied Cancer Research,. She is also a member of the Unites States and Canadian academy of pathology (USCAP), Hans Pooper Liver pathology society, and the International Academy of Pathology (IAP).
Laura Rubbia Brandt is the author of more than 200 scientific articles, book chapters and reviews.
Her research interests are pathogenesis of hepatic secondary effects neoadjuvant chemotherapy in colorectal metastasis and mechanisms and role of HCV infection in the development of hepatic steatosis.